Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parecoxib sodium after supratentorial brain tumor surgery
ChiCTR2000032300Phase 4Recruiting
- Sponsor
- Beijing Sanbo Brain Hospital
- Start
- Apr 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of parecoxib in supratentorial neoplasm (2 arms), sponsored by Beijing Sanbo Brain Hospital. Primary endpoint: Degree of brain edema. Started Apr 2020; status: recruiting.
02
Drugs
parecoxib
03
Conditions
supratentorial neoplasm
Beyond the preview
Go deeper on ChiCTR2000032300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032300.